CD20-positive B-cell Non-Hodgkin Lymphoma

Explore clinical trials studying CD20-positive B-cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

CD20-positive B-cell Non-Hodgkin Lymphoma trial results

Completed

NCT01569750

Conditions: CD20-positive B-cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: New York, United States

Rochester, New York, United States

Nashville, Tennessee, United States

Houston, Texas, United States

Active, Not Recruiting

NCT05395533

Conditions: CD20-positive B-cell Non-Hodgkin Lymphoma
Locations: Chinese Academy of Medical Sciences, Cancer Hospital Beijing, Beijing Municipality, China

Sun Yat-sen University Cancer Center (SYSUCC) Guangzhou, Guangdong, China

Henan Cancer Hospital (Affiliated Cancer Hospital of Zhengzhou University) Zhengzhou, Henan, China

The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China